Publications by authors named "M Grueber"
Positioning biologics in the treatment of IBD: A practical guide
Curr Res Pharmacol Drug Discov
April 2022
Article Synopsis
- The variety of biological therapies for inflammatory bowel disease (IBD) has significantly increased, with the number available doubling in the last decade and new treatments like interleukin 23p19 inhibitors being introduced.* -
- Properly positioning these advanced therapies based on factors such as clinical situation, effectiveness, and safety is essential for delivering personalized IBD treatment.* -
- This publication summarizes recent literature and expert insights to help integrate comparative efficacy data and patient demographics into clinical practice for better decision-making regarding biological therapies.*
From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases Inflammatory bowel diseases (IBD) are frequently accompanied by non-inflammatory joint pain and inflammatory spondyloarthritides. Spondyloarthritides can restrict joint function and typically manifest with inflammatory back pain with nightly pain and morning stiffness that improves upon exercising. In other patients, small or large peripheral joints are predominantly involved.
View Article and Find Full Text PDFEosinophilic cystitis is an unusual bladder lesion of unclear etiology first described in 1960. It usually causes irritative voiding symptoms and hematuria and in its rare tumor-like appearance the disease may mimic an invasive bladder neoplasm. In the report herein, a case of an 11-year-old boy with a tumor-forming eosinophilic cystitis is presented which was mistaken for an infiltrative vesical malignancy until the histopathological study was completed.
View Article and Find Full Text PDF